These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35986288)

  • 1. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
    Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
    J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.
    Stirm K; Leary P; Wüst D; Stark D; Joller N; Karakus U; Boyman O; Tzankov A; Müller A
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL).
    Dehghani M; Shokrgozar N; Ramzi M; Kalani M; Golmoghaddam H; Arandi N
    Cancer Immunol Immunother; 2021 Oct; 70(10):2961-2969. PubMed ID: 33721055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma: the significance of CD8
    Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
    J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells.
    Ma J; Yan S; Zhao Y; Yan H; Zhang Q; Li X
    Front Immunol; 2023; 14():1265255. PubMed ID: 37841254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
    Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
    Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8
    Xu Y; Liu Z; Lv L; Li P; Xiu B; Qian W; Liang A
    J Exp Clin Cancer Res; 2020 Nov; 39(1):238. PubMed ID: 33168024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
    Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
    Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
    Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
    J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chidamide enhances T-cell-mediated anti-tumor immune function by inhibiting NOTCH1/NFATC1 signaling pathway in ABC-type diffuse large B-cell lymphoma.
    Li L; Yang W; Pan Y; Ye R; Wang Y; Li S; Jiang H; Zhang Q; Wang X; Yan J
    Leuk Lymphoma; 2024 Jul; 65(7):895-910. PubMed ID: 38497543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and function of CD4
    Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
    Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
    Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
    Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
    Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
    Spasevska I; Sharma A; Steen CB; Josefsson SE; Blaker YN; Kolstad A; Rustad EH; Meyer S; Isaksen K; Chellappa S; Kushekhar K; Beiske K; Førsund MS; Spetalen S; Holte H; Østenstad B; Brodtkorb M; Kimby E; Olweus J; Taskén K; Newman AM; Lorenz S; Smeland EB; Alizadeh AA; Huse K; Myklebust JH
    Blood Adv; 2023 Dec; 7(23):7216-7230. PubMed ID: 37695745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of Tim-3
    Zhong W; Liu X; Zhu Z; Li Q; Li K
    Int Immunopharmacol; 2021 Jul; 96():107662. PubMed ID: 33864956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.